Guideline Archive

The Guideline Archive is a complete list of summaries that have been withdrawn from the NGC Web site. Information regarding a current NGC summary, where available, is provided. The list is organized alphabetically by guideline developer.
Measure Archive tabs, Updated Withdrawn Updated

The list below identifies guidelines that have been withdrawn from the NGC Web site.

Guideline summaries are removed from the NGC Web site because the guidelines they represent no longer meet the NGC Inclusion Criteria or the guideline developer indicated that the guideline should be withdrawn. Refer to the guideline developer's Web site, where available, for more information.

NGC currently contains 2832 individual guideline summaries that have been withdrawn.

A   B   C   D   E   F   G   H   I   J   K   M   N   O   P   R   S   T   U   V   W   All
 
Academy of Breastfeeding Medicine (11)
1.  
Breastfeeding the hypotonic infant. NGC:005883
Source(s): Thomas J, Marinelli KA, Hennessy M, Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #16: breastfeeding the hypotonic infant. Breastfeed Med. 2007 Jun;2(2):112-8. [38 references] PubMed External Web Site Policy
2.  
Contraception during breastfeeding. NGC:005877
Source(s): Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #13: contraception during breastfeeding. Breastfeed Med. 2006 Spring;1(1):43-51. [18 references] PubMed External Web Site Policy
3.  
Guideline on co-sleeping and breastfeeding. NGC:006818
Source(s): Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #6: guideline on co-sleeping and breastfeeding. Revision, March 2008. Breastfeed Med. 2008 Mar;3(1):38-43. PubMed External Web Site Policy
4.  
Guidelines for breastfeeding infants with cleft lip, cleft palate, or cleft lip and palate. NGC:006819
Source(s): Reilly S, Reid J, Skeat J, Academy of Breastfeeding Medicine Clinical Protocol Committee. ABM Clinical Protocol #17: Guidelines for breastfeeding infants with cleft lip, cleft palate, or cleft lip and palate. Breastfeed Med. 2007 Dec;2(4):243-50. PubMed External Web Site Policy
5.  
Guidelines for glucose monitoring and treatment of hypoglycemia in breastfed neonates. NGC:005865
Source(s): Wight N, Marinelli KA, Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #1: guidelines for glucose monitoring and treatment of hypoglycemia in breastfed neonates. Breastfeed Med. 2006 Autumn;1(3):178-84. [39 references] PubMed External Web Site Policy
6.  
Guidelines for hospital discharge of the breastfeeding term newborn and mother: "Going home protocol". NGC:005987
Source(s): Academy of Breastfeeding Medicine Clinical Protocol Committee. ABM Clinical Protocol #2 (2007 revision): guidelines for hospital discharge of the breastfeeding term newborn and mother: "the going home protocol". Breastfeed Med. 2007 Sep;2(3):158-65. [156 references] PubMed External Web Site Policy
7.  
Guidelines for the evaluation and management of neonatal ankyloglossia and its complications in the breastfeeding dyad. NGC:005875
Source(s): Academy of Breastfeeding Medicine. Guidelines for the evaluation and management of neonatal ankyloglossia and its complications in the breastfeeding dyad. New Rochelle (NY): Academy of Breastfeeding Medicine; 2004 Sep 3. 8 p. [24 references]
8.  
Mastitis. NGC:006816
Source(s): Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #4: mastitis. Revision, May 2008. Breastfeed Med. 2008 Sep;3(3):177-80. PubMed External Web Site Policy
9.  
Peripartum breastfeeding management for the healthy mother and infant at term. NGC:006817
Source(s): Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #5: peripartum breastfeeding management for the healthy mother and infant at term revision, June 2008. Breastfeed Med. 2008 Jun;3(2):129-32. PubMed External Web Site Policy
10.  
Transitioning the breastfeeding/breastmilk-fed premature infant from the neonatal intensive care unit to home. NGC:005876
Source(s): Academy of Breastfeeding Medicine. Transitioning the breastfeeding/breastmilk-fed premature infant from the neonatal intensive care unit to home. New Rochelle (NY): Academy of Breastfeeding Medicine; 2004 Sep 17. 12 p. [21 references]
11.  
Use of antidepressants in nursing mothers. NGC:006820
Source(s): Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #18: use of antidepressants in nursing mothers. Breastfeed Med. 2008 Mar;3(1):44-52. PubMed External Web Site Policy
Academy of Nutrition and Dietetics (9) (Web siteExternal Web Site Policy)
1.  
Adult weight management evidence-based nutrition practice guideline. NGC:006622
Source(s): American Dietetic Association (ADA). Adult weight management evidence based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2006 May. Various p. [151 references]
2.  
Chronic obstructive pulmonary disease (COPD) evidence-based nutrition practice guideline. NGC:007537
Source(s): American Dietetic Association (ADA). Chronic obstructive pulmonary disease (COPD) evidence-based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2008 Oct. Various p. [111 references]
3.  
Diabetes type 1 and 2 evidence-based nutrition practice guideline for adults. NGC:006618
Source(s): American Dietetic Association (ADA). Diabetes type 1 and 2 evidence-based nutrition practice guideline for adults. Chicago (IL): American Dietetic Association (ADA); 2008. Various p. [206 references]
4.  
Gestational diabetes mellitus (GDM). Evidence-based nutrition practice guideline. NGC:007374
Source(s): American Dietetic Association (ADA). Gestational diabetes mellitus (GDM). Evidence based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2008. Various p. [234 references]
5.  
Heart failure evidence-based nutrition practice guideline. NGC:006685
Source(s): American Dietetic Association (ADA). ADA heart failure: evidence-based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2008. Various p. [162 references]
6.  
Hyperlipidemia medical nutrition therapy protocol. NGC:002521
Source(s): American Dietetic Association. Hyperlipidemia medical nutrition therapy protocol. Chicago (IL): American Dietetic Association; 2001 Jun. Various p.
7.  
Hypertension evidence-based nutrition practice guideline. NGC:006619
Source(s): American Dietetic Association (ADA). Hypertension evidence based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2008. Various p. [3 references]
8.  
Oncology evidence-based nutrition practice guideline. NGC:006621
Source(s): American Dietetic Association (ADA). Oncology evidence-based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2007 Oct. Various p. [46 references]
9.  
Pediatric weight management evidence-based nutrition practice guideline. NGC:006623
Source(s): American Dietetic Association (ADA). Pediatric weight management evidence-based nutrition practice guideline. Chicago (IL): American Dietetic Association (ADA); 2007 Jun. Various p. [458 references]
Academy of Psychosomatic Medicine (1)
1.  
Practice guidelines for psychiatric consultation in the general medical setting. NGC:000928
Source(s): Bronheim HE, Fulop G, Kunkel EJ, Muskin PR, Schindler BA, Yates WR, Shaw R, Steiner H, Stern TA, Stoudemire A. The Academy of Psychosomatic Medicine practice guidelines for psychiatric consultation in the general medical setting. The Academy of Psychosomatic Medicine. Psychosomatics. 1998 Jul-Aug;39(4):S8-30. [138 references] PubMed External Web Site Policy
Action on Pre-eclampsia (1)
1.  
Pre-eclampsia community guideline. NGC:004253
Source(s): Action on Pre-Eclampsia (APEC). Pre-eclampsia community guideline. Middlesex (UK): Action on Pre-Eclampsia (APEC); 2004. 20 p.
Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, de Swiet M, Fletcher G, Jokinen M, Murphy D, Nelson-Piercy C, Osgood V, Robson S, Shennan A, Tuffnell A, Twaddle S, Waugh J. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ. 2005 Mar 12;330(7491):576-80. [24 references] PubMed External Web Site Policy
Agency for Health Quality and Assessment of Catalonia (AQuAS) (1)
1.  
Clinical practice guideline for primary and secondary prevention of stroke. NGC:009481
Source(s): Development Group of the Stroke Prevention Guideline. Clinical practice guideline for primary and secondary prevention of stroke. Madrid (Spain): Catalan Agency for Health Information, Assessment and Quality; 2008. 261 p. [624 references]
Agency for Healthcare Research and Quality (12) (Web siteExternal Web Site Policy)
1.  
Acute low back problems in adults. NGC:000090
Source(s): Agency for Health Care Policy and Research (AHCPR). Acute low back problems in adults. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Dec. 160 p. (Clinical practice guideline; no. 14).  [360 references]
2.  
Cardiac rehabilitation. NGC:000093
Source(s): Agency for Health Care Policy and Research (AHCPR), Cardiac Rehabilitation Guideline Panel. Cardiac rehabilitation. Rockville (MD): U. S. Department of Health and Human Services, Public Health Service, AHCPR ; 1995 Oct. 202 p. (Clinical practice guideline; no. 17).  [334 references]
3.  
Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. NGC:000086
Source(s): Agency for Health Care Policy and Research (AHCPR), Heart Failure Guideline Panel. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1994 Jun. 122 p. (Clinical practice guideline; no. 11).  [237 references]
4.  
Management of cancer pain. NGC:000087
Source(s): Agency for Health Care Policy and Research (AHCPR). Management of cancer pain. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994. 257 p. (Clinical practice guideline; no. 9). 
5.  
Otitis media with effusion in young children. NGC:000088
Source(s): Agency for Health Care Policy and Research (AHCPR), Otitis Media Guideline Panel. Otitis media with effusion in young children. Clinical practice guideline . Rockville (MD): U. S. Department of Health and Human Service, Public Health Service, AHCPR ; 1994. 108 p. (Clinical practice guideline; no. 12). 
6.  
Post-stroke rehabilitation. NGC:000092
Source(s): Agency for Health Care Policy and Research (AHCPR), Post-Stroke Rehabilitation Guideline Panel. Post-stroke rehabilitation. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1995 May. 248 p. (Clinical practice guideline; no. 16).  [334 references]
7.  
Pressure ulcers in adults: prediction and prevention. NGC:001827
Source(s): Agency for Health Care Policy and Research (AHCPR). Pressure ulcers in adults: prediction and prevention. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1992 May. 63 p. (Clinical practice guideline; no. 3).  [127 references]
8.  
Quality determinants of mammography. NGC:000089
Source(s): Agency for Health Care Policy and Research (AHCPR). Quality determinants of mammography. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Oct. 153 p. (Clinical practice guideline; no. 13).  [307 references]
9.  
Recognition and initial assessment of Alzheimer's disease and related dementias. NGC:000095
Source(s): Agency for Health Care Policy and Research (AHCPR). Recognition and initial assessment of Alzheimer's disease and related dementias. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Nov. 128 p. (Clinical practice guideline; no. 19).  [302 references]
10.  
Treatment of pressure ulcers. NGC:000008
Source(s): Agency for Health Care Policy and Research (AHCPR). Treatment of pressure ulcers. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Dec. 154 p. (Clinical practice guideline; no. 15).  [333 references]
11.  
Unstable angina: diagnosis and management. NGC:000085
Source(s): Agency for Health Care Policy and Research (AHCPR), National Heart, Lung, and Blood Institute. Unstable angina: diagnosis and management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Mar. 154 p. (Clinical practice guideline; no. 10). 
12.  
Urinary incontinence in adults: acute and chronic management. NGC:000078
Source(s): Agency for Health Care Policy and Research (AHCPR), Urinary Incontinence Guideline Panel. Urinary incontinence in adults: Acute and chronic management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Mar. 125 p. (Clinical practice guideline; no. 2). 
Alzheimer's Association (3)
1.  
Dementia care practice recommendations for assisted living residences and nursing homes. NGC:005562
Source(s): Tilly J, Reed P, editor(s). Dementia care practice recommendations for assisted living residences and nursing homes. Washington (DC): Alzheimer's Association; 2006 Sep. 28 p.
2.  
Dementia care practice recommendations for assisted living residences and nursing homes: phase 3 end-of-life care. NGC:006925
Source(s): Alzheimer's Association. Dementia care practice recommendations for assisted living residences and nursing homes. Phase 3 end-of-life care. Chicago (IL): Alzheimer's Association; 2007. 24 p.
3.  
Guideline for Alzheimer's disease management. NGC:006579
Source(s): California Workgroup on Guidelines for Alzheimer's Disease Management. Guideline for Alzheimer's disease management. Chicago (IL): Alzheimer's Association; 2008 Apr. 61 p. [396 references]
Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties (1)
1.  
Guidelines for Alzheimer's disease management. NGC:002383
Source(s): California Workgroup on Guidelines for Alzheimer's Disease Management. Guidelines for Alzheimer's disease management. Los Angeles (CA): Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties; 2002 Jan 1. 52 p. [296 references]
American Academy of Allergy, Asthma and Immunology (1) (Web siteExternal Web Site Policy)
1.  
Contact dermatitis: a practice parameter. NGC:006967
Source(s): American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 2006 Sep;97(3 Suppl 2):S1-38. [287 references] PubMed External Web Site Policy
American Academy of Child and Adolescent Psychiatry (27) (Web siteExternal Web Site Policy)
1.  
Practice parameter for psychiatric consultation to schools. NGC:004078
Source(s): Work Group on Schools. Walter, HJ, Berkovitz IH. Practice parameter for psychiatric consultation to schools. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2004. 21 p. [69 references]
2.  
Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. NGC:005512
Source(s): Connolly SD, Bernstein GA, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):267-83. [129 references] PubMed External Web Site Policy
3.  
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. NGC:005912
Source(s): Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. [190 references] PubMed External Web Site Policy
4.  
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. NGC:005511
Source(s): McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):107-25. [170 references] PubMed External Web Site Policy
5.  
Practice parameter for the assessment and treatment of children and adolescents with enuresis. NGC:004079
Source(s): Fritz G, Rockney R, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K. Practice parameter for the assessment and treatment of children and adolescents with enuresis. J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1540-50. [42 references] PubMed External Web Site Policy
Fritz G, Rockney R, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K. Practice parameter for the assessment and treatment of children and adolescents with enuresis. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2002. 18 p. [52 references]
6.  
Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. NGC:005513
Source(s): Steiner H, Remsing L, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):126-41. [108 references] PubMed External Web Site Policy
7.  
Practice parameter for the assessment and treatment of children and adolescents with reactive attachment disorder of infancy and early childhood. NGC:004221
Source(s): American Academy of Child and Adolescent Psychiatry (AACAP). Practice parameter for the assessment and treatment of children and adolescents with reactive attachment disorder of infancy and early childhood. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2005. 24 p. [101 references]
8.  
Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. NGC:002243
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2000 Jun 6. 40 p. [125 references]
Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7 Suppl):4S-23S. [125 references]
9.  
Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. NGC:004076
Source(s): Work Group on Quality Issues. Bukstein OG. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2004. 25 p. [112 references]
10.  
Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. NGC:002245
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2000 Oct 17. 55 p. [189 references]
Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7 Suppl):24S-51S. [189 references]
11.  
Practice parameter for the assessment and treatment of youth in juvenile detention and correctional facilities. NGC:004077
Source(s): Work Group On Quality Issues. Penn JV, Thomas C. Practice parameter for the assessment and treatment of youth in juvenile detention and correctional facilities. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2004. 19 p. [42 references]
12.  
Practice parameter for the assessment of the family. NGC:005923
Source(s): Josephson AM, AACAP Work Group on Quality Issues. Practice parameter for the assessment of the family. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):922-37. [50 references] PubMed External Web Site Policy
13.  
Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions with special reference to seclusion and restraint. NGC:002246
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions with special reference to seclusion and restraint. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2001 May 13. 81 p. [124 references]
Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):4S-25S. [125 references]
14.  
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. NGC:002244
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2001 Jun 4. 96 p. [164 references]
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. [164 references]
15.  
Practice parameter for use of electroconvulsive therapy with adolescents. NGC:004080
Source(s): Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1521-39. [73 references] PubMed External Web Site Policy
Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K. Practice parameter for use of electroconvulsive therapy with adolescents. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2002. 40 p. [81 references]
16.  
Practice parameter on child and adolescent mental health care in community systems of care. NGC:005514
Source(s): Winters NC, Pumariga A, Work Group on Community Child and Adolescent Psychiatry, Work Group on Quality Issues. Practice parameter on child and adolescent mental health care in community systems of care. J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):284-99. [64 references] PubMed External Web Site Policy
17.  
Practice parameters for child custody evaluation. NGC:000317
Source(s): Practice parameters for child custody evaluation. J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):57S-68S. [55 references]
18.  
Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. NGC:001368
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12 Suppl):32S-54S. [145 references]
19.  
Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. NGC:000322
Source(s): Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):122S-139S. [225 references]
20.  
Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. NGC:005924
Source(s): Birmaher B, Brent D, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Washington (DC): American Academy of Child and Adolescent Psychiatry (AACAP); 2007. 36 p. [181 references]
21.  
Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. NGC:000756
Source(s): Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10 Suppl):46S-62S. [130 references] PubMed External Web Site Policy
22.  
Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. NGC:000314
Source(s): Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10 Suppl):4S-26S. [99 references]
23.  
Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. NGC:001367
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12 Suppl):55S-76S. [173 references]
24.  
Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. NGC:001366
Source(s): American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12 Suppl):5S-31S. [117 references]
25.  
Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. NGC:000318
Source(s): Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry. 1997 Mar;36(3):423-42. [184 references]
Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):37S-56S. [184 references]
26.  
Practice parameters for the psychiatric assessment of children and adolescents. NGC:000313
Source(s): Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):4S-20S. [84 references]
27.  
Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). NGC:000315
Source(s): Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):21S-36S. [100 references]
American Academy of Clinical Toxicology (5) (Web siteExternal Web Site Policy)
1.  
Position statement: cathartics. NGC:001165
Source(s): Barceloux D, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists, McGuigan M, Hartigan-Go K. Position statement: cathartics. J Toxicol Clin Toxicol. 1997;35(7):743-52. [32 references] PubMed External Web Site Policy
2.  
Position statement: gastric lavage. NGC:001163
Source(s): Vale JA, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: gastric lavage. J Toxicol Clin Toxicol. 1997;35(7):711-9. [38 references] PubMed External Web Site Policy
3.  
Position statement: ipecac syrup. NGC:001167
Source(s): American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: ipecac syrup. Clin Toxicol. 1997;35(7):699-709. [41 references]
4.  
Position statement: single-dose activated charcoal. NGC:001164
Source(s): American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. Clin Toxicol. 1997;35(7):721-41. [112 references]
5.  
Position statement: whole bowel irrigation. NGC:001166
Source(s): Tenenbein M, European Association of Poisons Centres and Clinical Toxicologists. Position statement: whole bowel irrigation. European Association of Poisons Centres and Clinical Toxicologists European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):753-62. [29 references] PubMed External Web Site Policy
American Academy of Dermatology (4) (Web siteExternal Web Site Policy)
1.  
Guidelines of care for acne vulgaris management. NGC:005625
Source(s): Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R, American Academy of Dermatology/American Academy of Dermatology. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007 Apr;56(4):651-63. [180 references] PubMed External Web Site Policy
2.  
Guidelines of care for liposuction. NGC:001936
Source(s): Coleman WP 3rd, et al. Guidelines of care for liposuction. Guidelines/Outcomes Committee. J Am Acad Dermatol. 2001 Sep;45(3 Pt 1):438-47. [52 references]
3.  
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. NGC:006435
Source(s): Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May;58(5):826-50. [177 references] PubMed External Web Site Policy
4.  
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. NGC:006436
Source(s): Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May;58(5):851-64. [34 references] PubMed External Web Site Policy
American Academy of Family Physicians (4) (Web siteExternal Web Site Policy)
1.  
AAFP policy on antepartum oxytocin privileges. NGC:000439
Source(s): 1997-1998 AAFP reference manual - clinical policies. Kansas City (MO): AAFP; 1997. AAFP policy on antepartum oxytocin priveleges. p. 8 p. [9 references]
2.  
Benefits and risks of controlling blood glucose levels in patients with type 2 diabetes mellitus. NGC:001603
Source(s): American Academy of Family Physicians, American Diabetes Association. Controlling blood glucose levels in patients with type 2 diabetes mellitus. J Fam Pract. 2000 May;49(5):453-60. [110 references]
American Academy of Family Physicians. The benefits and risks of controlling blood glucose levels in patients with type 2 diabetes mellitus. A review of the evidence and recommendations American Academy of Family Physicians, American Diabetes Association. Leawood (KS): American Academy of Family Physicians (AAFP); 1999 Apr.
3.  
Management of minor closed head injury in children. NGC:001498
Source(s): American Academy of Pediatrics, American Academy of Family Physicians. Management of minor closed head injury in children. Pediatrics. 1999 Dec;104(6):1407-15. [31 references]
4.  
Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. NGC:004454
Source(s): Wall E, Roberts R, Deutchman M, Hueston W, Atwood LA, Ireland B. Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Leawood (KS): American Academy of Family Physicians (AAFP); 2005 Mar. 18 p. [38 references]
American Academy of Neurology (74) (Web siteExternal Web Site Policy)
1.  
(1) Assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (2) Addendum to assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:004514
Source(s): Armon C, Evans RW. Addendum to assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 Aug 23;65(4):510-2. [9 references] PubMed External Web Site Policy
Evans RW, Armon C, Frohman EM, Goodin DS. Assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2000 Oct 10;55(7):909-14. [52 references]
2.  
Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). NGC:003146
Source(s): Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology. 2002 Jul 9;59(1):13-22. [19 references] PubMed External Web Site Policy
Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002 Jul;33(7):1934-42. [19 references] PubMed External Web Site Policy
3.  
Assessment of brain SPECT. NGC:000640
Source(s): American Academy of Neurology. Assessment of brain SPECT. Neurology. 1996 Jan;46(1):278-85. [97 references] PubMed External Web Site Policy
4.  
Assessment of digital EEG, quantitative EEG, and EEG brain mapping. NGC:000651
Source(s): American Academy of Neurology, American Clinical Neurophysiology Society. Assessment of digital EEG, quantitative EEG, and EEG brain mapping. Neurology. 1997 Jul;49(1):277-92. [325 references] PubMed External Web Site Policy
5.  
Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:006657
Source(s): Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 6;70(19):1699-706. [35 references] PubMed External Web Site Policy
6.  
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:006656
Source(s): Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 6;70(19):1691-8. [48 references] PubMed External Web Site Policy
7.  
Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:006658
Source(s): Naumann M, So Y, Argoff CE, Childers MK, Dykstra DD, Gronseth GS, Jabbari B, Kaufmann HC, Schurch B, Silberstein SD, Simpson DM, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 6;70(19):1707-14. [34 references] PubMed External Web Site Policy
8.  
Assessment: clinical autonomic testing. NGC:000641
9.  
Assessment: dermatomal somatosensory evoked potentials. NGC:000653
Source(s): American Academy of Neurology, Therapeutics and Technology Assessments Subcommittee. Assessment: dermatomal somatosensory evoked potentials. Neurology. 1997 Oct;49(4):1127-30. [325 references] PubMed External Web Site Policy
10.  
Assessment: electronystagmography. NGC:000643
Source(s): Assessment: electronystagmography. Report of the Therapeutics and Technology Assessment Subcommittee. Neurology. 1996 Jun;46(6):1763-6. [9 references] PubMed External Web Site Policy
11.  
Assessment: melodic intonation therapy. NGC:000630
Source(s): American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Assessment: melodic intonation therapy. Neurology. 1994 Mar;44(3 Pt 1):566-8. [27 references] PubMed External Web Site Policy
12.  
Assessment: Neurologic risk of immunization. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:002050
Source(s): Fenichel GM. Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1999 May 12;52(8):1546-52. [30 references] PubMed External Web Site Policy
13.  
Assessment: neurological evaluation of male sexual dysfunction. NGC:000639
Source(s): Assessment: neurological evaluation of male sexual dysfunction. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1995 Dec;45(12):2287-92. [77 references] PubMed External Web Site Policy
14.  
Assessment: neuropsychological testing of adults. Considerations for neurologists. NGC:000645
Source(s): Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996 Aug;47(2):592-9. [57 references] PubMed External Web Site Policy
15.  
Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:006705
Source(s): Goodin DS, Cohen BA, O'Connor P, Kappos L, Stevens JC. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 Sep 2;71(10):766-73. [40 references] PubMed External Web Site Policy
16.  
Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:003644
Source(s): Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL, Lefkowitz D, Goldman RS, Armon C, Hsu CY, Goodin DS. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004 May 11;62(9):1468-81. [149 references] PubMed External Web Site Policy
17.  
Assessment: use of epidural steroid injections to treat radicular lumbosacral pain. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:005580
Source(s): Armon C, Argoff CE, Samuels J, Backonja MM, Therapeutics and Technology Assessment Subcommittee of the American. Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007 Mar 6;68(10):723-9. [27 references] PubMed External Web Site Policy
18.  
Carotid endarterectomy — an evidence-based review. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:004531
Source(s): Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J. Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 Sep 27;65(6):794-801. [27 references] PubMed External Web Site Policy
19.  
Clinical utility of surface EMG: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:002054
Source(s): Pullman SL, Goodin DS, Marquinez AI, Tabbal S, Rubin M. Clinical utility of surface EMG: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2000 Jul 25;55(2):171-7. [81 references]
20.  
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. NGC:003144
Source(s): Goodin DS, Frohman EM, Garmany GP Jr, Halper J, Likosky WH, Lublin FD, Silberberg DH, Stuart WH, van den Noort S. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002 Jan 22;58(2):169-78. [55 references] PubMed External Web Site Policy
21.  
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. NGC:003564
Source(s): French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the AES. Neurology. 2004 Apr 27;62(8):1252-60. [21 references] PubMed External Web Site Policy
22.  
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. NGC:003565
Source(s): French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the AES. Neurology. 2004 Apr 27;62(8):1261-73. [83 references] PubMed External Web Site Policy
23.  
Evaluation and management of intracranial mass lesions in AIDS. NGC:000654
Source(s): American Academy of Neurology, Quality Standards Subcommittee. Evaluation and management of intracranial mass lesions in AIDS. Neurology. 1998 Jan;50(1):21-6. [52 references] PubMed External Web Site Policy
24.  
Evaluation of surgery for Parkinson's disease. A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. NGC:002056
Source(s): Hallett M, Litvan I. Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. Neurology. 1999 Dec 10;53(9):1910-21. [109 references]
25.  
Evidence report: the medical treatment of ocular myasthenia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. NGC:005863
Source(s): Benatar M, Kaminski HJ, Quality Standards Subcommittee of the American Academy of Neurology. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007 Jun 12;68(24):2144-9. [20 references]
26.  
Immunization and multiple sclerosis: a summary of published evidence and recommendations. NGC:003148
Source(s): Rutschmann OT, McCrory DC, Matchar DB, Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. Immunization and MS: a summary of published evidence and recommendations. Neurology. 2002 Dec 24;59(12):1837-43. [29 references] PubMed External Web Site Policy
27.  
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. NGC:005579
Source(s): Goodin DS, Frohman EM, Hurwitz B, O'Connor PW, Oger JJ, Reder AT, Stevens JC. Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007 Mar 27;68(13):977-84. [57 references] PubMed External Web Site Policy